These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32850736)

  • 1. Optimization of a Soft Ensemble Vote Classifier for the Prediction of Chimeric Virus-Like Particle Solubility and Other Biophysical Properties.
    Vormittag P; Klamp T; Hubbuch J
    Front Bioeng Biotechnol; 2020; 8():881. PubMed ID: 32850736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ensembles of Hydrophobicity Scales as Potent Classifiers for Chimeric Virus-Like Particle Solubility - An Amino Acid Sequence-Based Machine Learning Approach.
    Vormittag P; Klamp T; Hubbuch J
    Front Bioeng Biotechnol; 2020; 8():395. PubMed ID: 32432098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Head-to-Head Comparison of Modular Vaccines Developed Using Different Capsid Virus-Like Particle Backbones and Antigen Conjugation Systems.
    Fredsgaard L; Goksøyr L; Thrane S; Aves KL; Theander TG; Sander AF
    Vaccines (Basel); 2021 May; 9(6):. PubMed ID: 34063871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of dendritic cells and induction of T cell responses by HPV 16 L1/E7 chimeric virus-like particles are enhanced by CpG ODN or sorbitol.
    Freyschmidt EJ; Alonso A; Hartmann G; Gissmann L
    Antivir Ther; 2004 Aug; 9(4):479-89. PubMed ID: 15456078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of human papillomavirus type 16 L1 chimeric virus-like particles versus L1/L2 chimeric virus-like particles in tumor prevention.
    Wakabayashi MT; Da Silva DM; Potkul RK; Kast WM
    Intervirology; 2002; 45(4-6):300-7. PubMed ID: 12566713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-component vaccine consisting of virus-like particles displaying hepatitis C virus envelope protein 2 oligomers.
    Prentoe J; Janitzek CM; Velázquez-Moctezuma R; Soerensen A; Jørgensen T; Clemmensen S; Soroka V; Thrane S; Theander T; Nielsen MA; Salanti A; Bukh J; Sander AF
    NPJ Vaccines; 2022 Nov; 7(1):148. PubMed ID: 36379958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterologous boosting increases immunogenicity of chimeric papillomavirus virus-like particle vaccines.
    Da Silva DM; Schiller JT; Kast WM
    Vaccine; 2003 Jul; 21(23):3219-27. PubMed ID: 12804851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and Purification of Tag/Catcher AP205-Based Capsid Virus-Like Particle Vaccines.
    Aves KL; Sander AF
    Methods Mol Biol; 2024; 2720():127-141. PubMed ID: 37775662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterologous papillomavirus virus-like particles and human papillomavirus virus-like particle immune complexes activate human Langerhans cells.
    Fausch SC; Da Silva DM; Kast WM
    Vaccine; 2005 Feb; 23(14):1720-9. PubMed ID: 15705478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PROSO II--a new method for protein solubility prediction.
    Smialowski P; Doose G; Torkler P; Kaufmann S; Frishman D
    FEBS J; 2012 Jun; 279(12):2192-200. PubMed ID: 22536855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza virus-like particles composed of conserved influenza proteins and GPI-anchored CCL28/GM-CSF fusion proteins enhance protective immunity against homologous and heterologous viruses.
    Liu J; Ren Z; Wang H; Zhao Y; Wilker PR; Yu Z; Sun W; Wang T; Feng N; Li Y; Wang H; Ji X; Li N; Yang S; He H; Qin C; Gao Y; Xia X
    Int Immunopharmacol; 2018 Oct; 63():119-128. PubMed ID: 30081250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Freeze-Drying of a Capsid Virus-like Particle-Based Platform Allows Stable Storage of Vaccines at Ambient Temperature.
    Aves KL; Janitzek CM; Fougeroux CE; Theander TG; Sander AF
    Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response to human papillomavirus 16 L1E7 chimeric virus-like particles: induction of cytotoxic T cells and specific tumor protection.
    Schäfer K; Müller M; Faath S; Henn A; Osen W; Zentgraf H; Benner A; Gissmann L; Jochmus I
    Int J Cancer; 1999 Jun; 81(6):881-8. PubMed ID: 10362134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of hydrophobicity scales for predicting biophysical properties of antibodies.
    Waibl F; Fernández-Quintero ML; Wedl FS; Kettenberger H; Georges G; Liedl KR
    Front Mol Biosci; 2022; 9():960194. PubMed ID: 36120542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using the concept of Chou's pseudo amino acid composition to predict protein solubility: an approach with entropies in information theory.
    Xiaohui N; Nana L; Jingbo X; Dingyan C; Yuehua P; Yang X; Weiquan W; Dongming W; Zengzhen W
    J Theor Biol; 2013 Sep; 332():211-7. PubMed ID: 23524162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Evaluation on Different Machine Learning Algorithms for Classification and Prediction of Antifungal Peptides.
    Mousavizadegan M; Mohabatkar H
    Med Chem; 2016; 12(8):795-800. PubMed ID: 26924627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encapsidating artificial human papillomavirus-16 mE7 protein in human papillomavirus-6b L1/L2 virus like particles.
    Xu YF; Wang QY; Zhang HT; Han YH; Song GX; Xu XM
    Chin Med J (Engl); 2007 Mar; 120(6):503-8. PubMed ID: 17439745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with an HPV-16 L1-based chimeric virus-like particle containing HPV-16 E6 and E7 epitopes elicits long-lasting prophylactic and therapeutic efficacy in an HPV-16 tumor mice model.
    Monroy-García A; Gómez-Lim MA; Weiss-Steider B; Hernández-Montes J; Huerta-Yepez S; Rangel-Santiago JF; Santiago-Osorio E; Mora García Mde L
    Arch Virol; 2014 Feb; 159(2):291-305. PubMed ID: 23990055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ToxiM: A Toxicity Prediction Tool for Small Molecules Developed Using Machine Learning and Chemoinformatics Approaches.
    Sharma AK; Srivastava GN; Roy A; Sharma VK
    Front Pharmacol; 2017; 8():880. PubMed ID: 29249969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective humoral immunity in guinea pigs induced by PCV2 virus-like particles displaying the B cell linear epitope (
    Wang N; Zhang S; Wang D; Li F; Liang L; Li X; Zou Y; Zhan Y; Chen G; Yu W; Deng Z; Tu D; Cui S
    Vet Microbiol; 2019 Aug; 235():86-92. PubMed ID: 31282383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.